After investing almost $3 million more cash in its operations, including $1 million more than the same quarter a year ago for gene therapy research…

The Wharton School alumnus and experienced chief financial officer Keith A. Goldan will stick around in Chester County in the wake of a major deal…

Kimberly M. Smith is new interim chief financial officer, treasurer and corporate secretary at Fibrocell Science, Inc.

David Pernock, Fibrocell’s chairman and CEO, thanked…

Its been a busy week for the people at Fibrocell, the Exton based autologous cell therapy company focused on developing first-in-class treatments for…

What’s going on with Fibrocell Science’s (FCSC) shares?

According to Zacks Investment Research, the online research company, shares of the Exton based cell…

Exton based Fibrocell Science, Inc. recently reported its first quarter financials and what the company believes is a strong start for 2014.

The company, in…

Chester County cell therapy developer Fibrocell Science Inc. of Exton expects to file its first quarter financial report this week after a five-day delay…